Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis
CONCLUSION: This study highlights the need for early screening and proactive management of metabolic risk factors for patients with NAFLD/NASH. The findings indicate a notable prevalence of obesity in the study population, a need for specialist referral for those at High-Risk of advanced fibrosis, and the importance of routine labs to evaluate metabolic factors. Primary care providers may be ideal providers to target these interventions and address this care need.PMID:38032542 | DOI:10.1080/00325481.2023.2288560
Source: Postgraduate Medicine - Category: Internal Medicine Authors: Anthony Yu Alexandra Ritenour Jennifer Vincent Chanhyun Park Karen Rascati Paul Godley Source Type: research
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Electronic Health Records (EHR) | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Hypertension | Information Technology | Internal Medicine | Liver | Liver Disease | Medicare | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Primary Care | Smokers | Study | Urology & Nephrology